MGP Ingredients (MGPI) Financials

$24.22 -0.20 (-0.81%)

As of 11:14 AM Eastern

Annual Income Statements for MGP Ingredients

This table shows MGP Ingredients' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	109	106	34
Consolidated Net Income / (Loss)	109	107	34
Net Income / (Loss) Continuing Operations	109	107	34
Total Pre-Tax Income	140	142	68
Total Operating Income	149	149	74
Total Gross Profit	253	305	286
Total Revenue	782	837	704
Operating Revenue	782	837	704
Total Cost of Revenue	529	532	417
Operating Cost of Revenue	529	532	417
Total Operating Expenses	104	156	212
Selling, General & Admin Expense	75	91	81
Marketing Expense	30	38	41
Impairment Charge	0.00	19	74
Other Special Charges / (Income)	0.00	7.10	16
Total Other Income / (Expense), net	-8.79	-6.87	-5.98
Interest & Investment Income	-5.45	-6.65	-8.44
Other Income / (Expense), net	-3.34	-0.22	2.46
Income Tax Expense	31	35	34
Net Income / (Loss) Attributable to Noncontrolling Interest	0.28	0.73	0.18
Basic Earnings per Share	$4.94	$4.82	$1.56
Weighted Average Basic Shares Outstanding	22.00M	22.06M	22.02M
Diluted Earnings per Share	$108,591,004.92	$4.80	$1.56
Weighted Average Diluted Shares Outstanding	22.05M	22.17M	22.02M
Weighted Average Basic & Diluted Shares Outstanding	22.00M	22.07M	21.27M
Cash Dividends to Common per Share	$0.48	$0.48	$0.48

This table shows MGP Ingredients' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	24	23	31	32	13	31	20	32	24	-41
Consolidated Net Income / (Loss)	24	23	31	32	13	31	21	32	24	-42
Net Income / (Loss) Continuing Operations	24	23	31	32	13	31	21	32	24	-42
Total Pre-Tax Income	31	28	41	43	17	41	27	42	31	-32
Total Operating Income	34	30	42	44	20	43	29	43	33	-30
Total Gross Profit	59	63	70	76	73	85	63	83	66	74
Total Revenue	201	191	201	209	212	215	171	191	161	181
Operating Revenue	201	191	201	209	212	215	171	191	161	181
Total Cost of Revenue	142	128	131	133	138	130	108	108	96	106
Operating Cost of Revenue	142	128	131	133	138	130	108	108	96	106
Total Operating Expenses	25	33	28	32	54	42	34	40	33	105
Selling, General & Admin Expense	18	23	21	24	22	26	21	23	17	20
Marketing Expense	7.28	11	7.73	8.64	9.51	12	8.68	12	9.65	11
Impairment Charge	0.00	-	0.00	0.00	18	1.06	0.12	0.02	0.00	74
Other Special Charges / (Income)	0.00	-	0.00	0.00	4.20	2.90	4.10	5.40	6.40	0.20
Total Other Income / (Expense), net	-2.70	-1.94	-0.87	-1.38	-2.38	-2.24	-2.07	-1.26	-1.15	-1.50
Interest & Investment Income	-1.35	-0.96	-1.00	-1.28	-2.35	-2.02	-2.02	-2.21	-2.17	-2.04
Other Income / (Expense), net	-1.35	-0.98	0.12	-0.09	-0.03	-0.23	-0.05	0.94	1.03	0.54
Income Tax Expense	7.53	5.26	9.66	11	4.37	9.78	6.26	10	7.55	10
Net Income / (Loss) Attributable to Noncontrolling Interest	0.01	0.00	0.27	0.16	0.01	0.29	0.19	0.28	0.21	-0.51
Basic Earnings per Share	$1.07	$1.03	$1.40	$1.44	$0.59	$1.39	$0.92	$1.43	$1.07	($1.86)
Weighted Average Basic Shares Outstanding	22.01M	22.00M	22.04M	22.06M	22.07M	22.06M	22.14M	22.12M	22.07M	22.02M
Diluted Earnings per Share	$1.06	$108,591,001.02	$1.39	$1.44	$0.58	$1.39	$0.92	$1.43	$1.07	($1.86)
Weighted Average Diluted Shares Outstanding	22.23M	22.05M	22.07M	22.14M	22.38M	22.17M	22.14M	22.12M	22.07M	22.02M
Weighted Average Basic & Diluted Shares Outstanding	21.99M	22.00M	22.01M	22.02M	22.02M	22.07M	22.01M	21.99M	21.95M	21.27M

This table details how cash moves in and out of MGP Ingredients' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	26	-30	6.89
Net Cash From Operating Activities	89	84	102
Net Cash From Continuing Operating Activities	89	84	102
Net Income / (Loss) Continuing Operations	109	107	34
Consolidated Net Income / (Loss)	109	107	34
Depreciation Expense	21	22	22
Non-Cash Adjustments To Reconcile Net Income	7.92	31	77
Changes in Operating Assets and Liabilities, net	-49	-77	-31
Net Cash From Investing Activities	-48	-159	-72
Net Cash From Continuing Investing Activities	-48	-159	-72
Purchase of Property, Plant & Equipment	-45	-55	-71
Acquisitions	-2.81	-104	0.00
Other Investing Activities, net	0.32	-0.26	-0.38
Net Cash From Financing Activities	-15	46	-24
Net Cash From Continuing Financing Activities	-15	46	-24
Repayment of Debt	-3.40	-48	-89
Repurchase of Common Equity	-0.72	-0.80	-49
Payment of Dividends	-11	-11	-11
Issuance of Debt	0.00	105	125
Other Net Changes in Cash	-	-	-0.03

This table details how cash moves in and out of MGP Ingredients' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	13	-2.79	-16	-9.77	6.07	-9.64	1.11	1.51	-0.24	4.50
Net Cash From Operating Activities	29	17	5.02	15	28	35	25	4.96	44	29
Net Cash From Continuing Operating Activities	29	17	5.02	15	28	35	25	4.97	44	28
Net Income / (Loss) Continuing Operations	24	23	31	32	13	31	21	32	24	-42
Consolidated Net Income / (Loss)	24	23	31	32	13	31	21	32	24	-42
Depreciation Expense	5.33	5.20	5.17	5.32	5.78	5.84	5.29	5.33	5.68	5.69
Non-Cash Adjustments To Reconcile Net Income	2.34	3.37	1.57	2.85	20	6.54	1.57	0.07	0.09	75
Changes in Operating Assets and Liabilities, net	-2.06	-14	-33	-25	-11	-8.25	-2.82	-32	14	-10
Net Cash From Investing Activities	-12	-16	-17	-119	-11	-13	-27	-6.39	-19	-18
Net Cash From Continuing Investing Activities	-12	-16	-17	-119	-11	-13	-27	-6.39	-19	-18
Purchase of Property, Plant & Equipment	-11	-16	-16	-14	-12	-13	-27	-6.37	-19	-18
Other Investing Activities, net	0.05	0.64	-0.71	-0.43	0.22	0.65	-0.24	-0.02	-0.02	-0.10
Net Cash From Financing Activities	-3.65	-3.46	-4.27	94	-11	-32	3.77	2.95	-25	-5.76
Net Cash From Continuing Financing Activities	-3.65	-3.46	-4.27	94	-11	-32	3.77	2.95	-25	-5.76
Repayment of Debt	-0.99	-0.80	-0.80	-8.60	-8.60	-30	-17	-12	-40	-22
Repurchase of Common Equity	-0.00	-0.00	-0.80	-	-	-	-6.96	-2.77	-2.50	-37
Payment of Dividends	-2.66	-2.66	-2.67	-2.67	-2.67	-2.67	-2.67	-2.67	-2.67	-2.62
Issuance of Debt	-	-	0.00	105	-	-	30	20	20	55

This table presents MGP Ingredients' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,158	1,392	1,406
Total Current Assets	454	514	546
Cash & Equivalents	48	18	25
Accounts Receivable	109	144	148
Inventories, net	290	347	365
Prepaid Expenses	2.96	3.58	3.98
Current Deferred & Refundable Income Taxes	4.33	1.19	3.45
Plant, Property, & Equipment, net	236	262	317
Total Noncurrent Assets	468	616	543
Long-Term Investments	5.53	5.20	7.02
Goodwill	226	322	248
Intangible Assets	217	272	268
Other Noncurrent Operating Assets	20	17	20
Total Liabilities & Shareholders' Equity	1,158	1,392	1,406
Total Liabilities	413	543	573
Total Current Liabilities	105	114	92
Short-Term Debt	5.60	6.40	6.40
Accounts Payable	66	74	66
Accrued Expenses	29	32	14
Other Taxes Payable	4.63	2.25	5.36
Total Noncurrent Liabilities	307	429	481
Long-Term Debt	225	281	317
Noncurrent Deferred & Payable Income Tax Liabilities	67	63	63
Other Noncurrent Operating Liabilities	15	85	100
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	746	849	833
Total Preferred & Common Equity	747	850	834
Preferred Stock	0.00	0.00	0.00
Total Common Equity	747	850	834
Common Stock	326	332	339
Retained Earnings	443	540	564
Treasury Stock	-22	-21	-68
Accumulated Other Comprehensive Income / (Loss)	-0.30	-0.40	-0.66
Noncontrolling Interest	-1.08	-1.43	-1.62

This table presents MGP Ingredients' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	1,132	1,184	1,395	1,366	1,390	1,434	1,441
Total Current Assets	441	475	521	504	507	546	532
Cash & Equivalents	51	32	22	28	19	21	21
Accounts Receivable	108	129	148	127	133	159	130
Inventories, net	275	309	344	342	349	359	372
Prepaid Expenses	5.83	6.54	5.18	4.60	5.48	4.80	4.69
Current Deferred & Refundable Income Taxes	1.01	0.00	2.32	2.19	0.00	3.01	3.96
Plant, Property, & Equipment, net	221	241	251	243	271	276	292
Plant, Property & Equipment, gross	431	461	475	466	503	512	533
Accumulated Depreciation	210	220	225	222	232	236	241
Total Noncurrent Assets	471	468	624	619	612	612	616
Long-Term Investments	6.14	5.27	4.96	5.34	4.90	5.81	6.64
Goodwill	226	226	326	322	322	322	322
Intangible Assets	217	216	271	273	271	270	269
Other Noncurrent Operating Assets	21	20	22	20	15	15	19
Total Liabilities & Shareholders' Equity	1,132	1,184	1,395	1,366	1,390	1,434	1,441
Total Liabilities	408	408	588	548	525	541	528
Total Current Liabilities	101	102	119	90	80	85	82
Short-Term Debt	4.80	6.40	6.40	6.40	6.40	6.40	6.40
Accounts Payable	65	67	85	54	50	56	54
Accrued Expenses	26	17	21	27	16	18	20
Other Taxes Payable	4.71	7.39	5.95	2.72	3.80	4.49	2.48
Total Noncurrent Liabilities	307	306	469	458	444	456	445
Long-Term Debt	226	223	319	310	294	303	284
Noncurrent Deferred & Payable Income Tax Liabilities	66	68	69	65	64	63	62
Other Noncurrent Operating Liabilities	15	15	81	83	86	90	100
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	724	776	807	818	866	893	913
Total Preferred & Common Equity	725	777	808	820	867	894	914
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	725	777	808	820	867	894	914
Common Stock	324	328	329	330	336	336	337
Retained Earnings	423	471	501	511	558	587	609
Treasury Stock	-22	-22	-21	-21	-27	-29	-31
Accumulated Other Comprehensive Income / (Loss)	-0.86	-0.24	-0.17	-0.48	-0.44	-0.55	-0.02
Noncontrolling Interest	-0.93	-1.12	-1.28	-1.40	-1.48	-1.54	-1.59

This table displays calculated financial ratios and metrics derived from MGP Ingredients' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	24.83%	6.92%	-15.89%
EBITDA Growth	15.85%	2.05%	-42.01%
EBIT Growth	16.37%	1.90%	-48.19%
NOPAT Growth	22.09%	-2.92%	-66.63%
Net Income Growth	19.88%	-1.60%	-67.83%
EPS Growth	19.86%	-100.00%	-67.50%
Operating Cash Flow Growth	0.76%	-5.79%	22.07%
Free Cash Flow Firm Growth	109.31%	-275.75%	133.94%
Invested Capital Growth	8.39%	20.61%	0.99%
Revenue Q/Q Growth	3.18%	2.94%	-4.62%
EBITDA Q/Q Growth	-8.77%	9.47%	-42.44%
EBIT Q/Q Growth	-9.81%	10.51%	-48.62%
NOPAT Q/Q Growth	-7.28%	8.39%	-66.72%
Net Income Q/Q Growth	6.12%	8.66%	-67.94%
EPS Q/Q Growth	131.49%	-100.00%	-67.57%
Operating Cash Flow Q/Q Growth	-0.89%	28.33%	-5.90%
Free Cash Flow Firm Q/Q Growth	-34.65%	21.96%	-31.69%
Invested Capital Q/Q Growth	2.72%	1.02%	-4.39%
Profitability Metrics	-	-	-
Gross Margin	32.38%	36.43%	40.69%
EBITDA Margin	21.36%	20.38%	14.05%
Operating Margin	19.04%	17.77%	10.58%
EBIT Margin	18.61%	17.74%	10.93%
Profit (Net Income) Margin	13.92%	12.81%	4.90%
Tax Burden Percent	77.67%	75.58%	50.36%
Interest Burden Percent	96.26%	95.52%	89.02%
Effective Tax Rate	22.33%	24.42%	49.64%
Return on Invested Capital (ROIC)	13.05%	11.04%	3.35%
ROIC Less NNEP Spread (ROIC-NNEP)	9.49%	8.68%	2.27%
Return on Net Nonoperating Assets (RNNOA)	2.62%	2.40%	0.75%
Return on Equity (ROE)	15.67%	13.44%	4.10%
Cash Return on Invested Capital (CROIC)	4.99%	-7.65%	2.36%
Operating Return on Assets (OROA)	13.24%	11.64%	5.50%
Return on Assets (ROA)	9.90%	8.40%	2.46%
Return on Common Equity (ROCE)	15.68%	13.46%	4.11%
Return on Equity Simple (ROE_SIMPLE)	14.58%	12.60%	4.13%
Net Operating Profit after Tax (NOPAT)	116	112	37
NOPAT Margin	14.79%	13.43%	5.33%
Net Nonoperating Expense Percent (NNEP)	3.56%	2.36%	1.09%
Return On Investment Capital (ROIC_SIMPLE)	11.85%	9.88%	3.24%
Cost of Revenue to Revenue	67.62%	63.57%	59.31%
SG&A Expenses to Revenue	9.54%	10.93%	11.57%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.34%	18.66%	30.11%
Earnings before Interest and Taxes (EBIT)	146	148	77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	167	171	99
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	3.10	2.53	1.04
Price to Tangible Book Value (P/TBV)	7.62	8.38	2.72
Price to Revenue (P/Rev)	2.96	2.58	1.23
Price to Earnings (P/E)	21.30	20.25	25.21
Dividend Yield	0.46%	0.49%	1.22%
Earnings Yield	4.69%	4.94%	3.97%
Enterprise Value to Invested Capital (EV/IC)	2.70	2.17	1.03
Enterprise Value to Revenue (EV/Rev)	3.18	2.89	1.64
Enterprise Value to EBITDA (EV/EBITDA)	14.90	14.17	11.67
Enterprise Value to EBIT (EV/EBIT)	17.09	16.29	15.01
Enterprise Value to NOPAT (EV/NOPAT)	21.51	21.52	30.79
Enterprise Value to Operating Cash Flow (EV/OCF)	27.99	28.85	11.28
Enterprise Value to Free Cash Flow (EV/FCFF)	56.19	0.00	43.67
Leverage & Solvency	-	-	-
Debt to Equity	0.31	0.34	0.39
Long-Term Debt to Equity	0.30	0.33	0.38
Financial Leverage	0.28	0.28	0.33
Leverage Ratio	1.58	1.60	1.66
Compound Leverage Factor	1.52	1.53	1.48
Debt to Total Capital	23.60%	25.28%	27.99%
Short-Term Debt to Total Capital	0.57%	0.56%	0.55%
Long-Term Debt to Total Capital	23.03%	24.72%	27.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.11%	-0.13%	-0.14%
Common Equity to Total Capital	76.51%	74.85%	72.15%
Debt to EBITDA	1.38	1.68	3.27
Net Debt to EBITDA	1.06	1.55	2.95
Long-Term Debt to EBITDA	1.35	1.65	3.21
Debt to NOPAT	1.99	2.56	8.63
Net Debt to NOPAT	1.53	2.35	7.77
Long-Term Debt to NOPAT	1.94	2.50	8.46
Altman Z-Score	5.35	4.22	2.53
Noncontrolling Interest Sharing Ratio	-0.11%	-0.16%	-0.18%
Liquidity Ratios	-	-	-
Current Ratio	4.31	4.51	5.91
Quick Ratio	1.49	1.43	1.88
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	44	-78	26
Operating Cash Flow to CapEx	196.23%	151.60%	143.69%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.71	0.66	0.50
Accounts Receivable Turnover	7.75	6.60	4.81
Inventory Turnover	1.98	1.67	1.17
Fixed Asset Turnover	3.53	3.36	2.43
Accounts Payable Turnover	8.81	7.60	5.96
Days Sales Outstanding (DSO)	47.07	55.32	75.94
Days Inventory Outstanding (DIO)	184.78	218.45	311.29
Days Payable Outstanding (DPO)	41.44	48.05	61.20
Cash Conversion Cycle (CCC)	190.41	225.72	326.03
Capital & Investment Metrics	-	-	-
Invested Capital	923	1,113	1,124
Invested Capital Turnover	0.88	0.82	0.63
Increase / (Decrease) in Invested Capital	71	190	11
Enterprise Value (EV)	2,489	2,417	1,154
Market Capitalization	2,313	2,155	864
Book Value per Share	$33.95	$38.63	$38.00
Tangible Book Value per Share	$13.81	$11.68	$14.48
Total Capital	976	1,136	1,156
Total Debt	230	287	324
Total Long-Term Debt	225	281	317
Net Debt	177	264	291
Capital Expenditures (CapEx)	45	55	71
Debt-free, Cash-free Net Working Capital (DFCFNWC)	306	388	435
Debt-free Net Working Capital (DFNWC)	354	407	460
Net Working Capital (NWC)	349	400	454
Net Nonoperating Expense (NNE)	6.83	5.19	3.01
Net Nonoperating Obligations (NNO)	177	264	291
Total Depreciation and Amortization (D&A)	21	22	22
Debt-free, Cash-free Net Working Capital to Revenue	39.18%	46.41%	61.80%
Debt-free Net Working Capital to Revenue	45.30%	48.60%	65.39%
Net Working Capital to Revenue	44.58%	47.84%	64.48%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.00	$4.82	$1.56
Adjusted Weighted Average Basic Shares Outstanding	0.00	22.06M	22.02M
Adjusted Diluted Earnings per Share	$0.00	$4.80	$1.56
Adjusted Weighted Average Diluted Shares Outstanding	0.00	22.17M	22.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	22.07M	21.27M
Normalized Net Operating Profit after Tax (NOPAT)	116	132	83
Normalized NOPAT Margin	14.79%	15.82%	11.77%
Pre Tax Income Margin	17.92%	16.94%	9.73%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	9.78%	9.96%	30.84%
Augmented Payout Ratio	10.44%	10.71%	172.36%

This table displays calculated financial ratios and metrics derived from MGP Ingredients' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.89%	14.47%	2.96%	7.19%	5.21%	12.51%	-15.15%	-8.71%	-23.70%	-15.87%
EBITDA Growth	0.37%	-32.12%	-15.97%	24.84%	-32.36%	43.49%	-27.10%	0.59%	53.42%	-149.73%
EBIT Growth	0.15%	-35.52%	-16.86%	28.64%	-39.05%	49.12%	-30.75%	0.64%	69.53%	-169.79%
NOPAT Growth	3.40%	-27.42%	-17.80%	20.49%	-42.09%	35.98%	-30.05%	-0.05%	66.33%	-165.07%
Net Income Growth	-0.19%	38.69%	-16.96%	26.03%	-44.61%	37.91%	-33.67%	0.17%	82.32%	-235.28%
EPS Growth	-100.00%	131.49%	-17.75%	25.22%	-45.28%	-100.00%	-33.81%	-0.69%	84.48%	-233.81%
Operating Cash Flow Growth	25.30%	-4.55%	-77.41%	-27.20%	-2.69%	110.86%	390.40%	-67.23%	54.42%	-18.23%
Free Cash Flow Firm Growth	94.09%	91.19%	89.26%	-314.70%	-501.78%	-232.68%	-158.76%	79.39%	73.89%	79.44%
Invested Capital Growth	6.78%	8.39%	10.26%	23.94%	22.65%	20.61%	17.90%	6.35%	6.71%	0.99%
Revenue Q/Q Growth	3.16%	-5.05%	5.24%	3.98%	1.26%	1.54%	-20.63%	11.87%	-15.38%	11.98%
EBITDA Q/Q Growth	-4.31%	-10.34%	38.08%	5.37%	-48.15%	90.22%	-29.85%	45.40%	-20.92%	-161.66%
EBIT Q/Q Growth	-5.06%	-11.62%	45.06%	5.68%	-55.02%	116.25%	-32.63%	53.58%	-24.23%	-189.03%
NOPAT Q/Q Growth	-6.23%	-6.21%	31.61%	4.08%	-54.93%	120.24%	-32.30%	48.73%	-24.99%	-186.15%
Net Income Q/Q Growth	-6.84%	-4.73%	37.85%	3.00%	-59.05%	137.21%	-33.70%	55.54%	-25.47%	-276.00%
EPS Q/Q Growth	-7.83%	10,244,433,958.49%	-100.00%	3.60%	-59.72%	139.66%	-33.81%	55.43%	-25.17%	-273.83%
Operating Cash Flow Q/Q Growth	40.62%	-42.93%	-69.90%	201.43%	87.97%	23.65%	-30.00%	-79.86%	785.86%	-34.52%
Free Cash Flow Firm Q/Q Growth	28.03%	-51.05%	-23.51%	-208.83%	-4.44%	16.50%	3.93%	75.40%	-32.30%	34.24%
Invested Capital Q/Q Growth	0.70%	2.72%	4.99%	14.12%	-0.35%	1.02%	2.63%	2.94%	0.00%	-4.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.36%	33.10%	34.74%	36.50%	34.71%	39.62%	36.82%	43.62%	40.76%	41.19%
EBITDA Margin	18.81%	17.77%	23.31%	23.62%	12.10%	22.66%	20.02%	26.03%	24.32%	-13.39%
Operating Margin	16.84%	15.56%	20.68%	21.12%	9.37%	20.04%	16.95%	22.74%	20.17%	-16.84%
EBIT Margin	16.16%	15.04%	20.74%	21.08%	9.36%	19.94%	16.92%	23.23%	20.80%	-16.54%
Profit (Net Income) Margin	11.75%	11.79%	15.44%	15.29%	6.18%	14.45%	12.07%	16.78%	14.78%	-23.23%
Tax Burden Percent	75.83%	81.05%	76.27%	74.74%	74.96%	76.04%	76.67%	76.00%	75.95%	131.47%
Interest Burden Percent	95.85%	96.66%	97.61%	97.09%	88.12%	95.29%	93.01%	95.03%	93.53%	106.83%
Effective Tax Rate	24.17%	18.95%	23.73%	25.26%	25.04%	23.96%	23.33%	24.00%	24.05%	0.00%
Return on Invested Capital (ROIC)	11.13%	11.12%	13.46%	12.68%	5.71%	12.53%	9.93%	11.94%	9.93%	-7.42%
ROIC Less NNEP Spread (ROIC-NNEP)	10.11%	10.30%	13.12%	12.26%	4.93%	11.75%	9.25%	11.61%	9.61%	-14.87%
Return on Net Nonoperating Assets (RNNOA)	3.02%	2.85%	3.53%	3.95%	1.46%	3.25%	2.64%	3.97%	3.03%	-4.91%
Return on Equity (ROE)	14.15%	13.97%	16.99%	16.63%	7.17%	15.78%	12.57%	15.91%	12.96%	-12.32%
Cash Return on Invested Capital (CROIC)	7.80%	4.99%	2.02%	-9.92%	-9.98%	-7.65%	-6.69%	2.86%	3.40%	2.36%
Operating Return on Assets (OROA)	11.40%	10.70%	14.46%	13.52%	6.09%	13.08%	10.60%	12.94%	10.94%	-8.32%
Return on Assets (ROA)	8.29%	8.38%	10.76%	9.81%	4.02%	9.48%	7.56%	9.35%	7.77%	-11.68%
Return on Common Equity (ROCE)	14.17%	13.99%	17.01%	16.66%	7.19%	15.80%	12.59%	15.93%	12.98%	-12.35%
Return on Equity Simple (ROE_SIMPLE)	14.15%	0.00%	13.19%	13.50%	12.03%	0.00%	11.15%	10.81%	11.76%	0.00%
Net Operating Profit after Tax (NOPAT)	26	24	32	33	15	33	22	33	25	-21
NOPAT Margin	12.77%	12.61%	15.77%	15.79%	7.03%	15.24%	13.00%	17.28%	15.32%	-11.79%
Net Nonoperating Expense Percent (NNEP)	1.02%	0.82%	0.34%	0.42%	0.78%	0.77%	0.68%	0.33%	0.32%	7.46%
Return On Investment Capital (ROIC_SIMPLE)	-	2.47%	-	-	-	2.88%	-	-	-	-1.84%
Cost of Revenue to Revenue	70.64%	66.90%	65.26%	63.50%	65.29%	60.38%	63.18%	56.38%	59.24%	58.81%
SG&A Expenses to Revenue	8.90%	11.85%	10.21%	11.25%	10.19%	12.00%	12.30%	11.93%	10.66%	11.31%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	12.52%	17.54%	14.06%	15.38%	25.33%	19.58%	19.86%	20.88%	20.59%	58.03%
Earnings before Interest and Taxes (EBIT)	33	29	42	44	20	43	29	44	34	-30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	38	34	47	49	26	49	34	50	39	-24
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.19	3.10	2.72	2.87	2.82	2.53	2.18	1.83	2.00	1.04
Price to Tangible Book Value (P/TBV)	8.22	7.62	6.31	11.00	10.24	8.38	6.89	5.40	5.66	2.72
Price to Revenue (P/Rev)	3.05	2.96	2.68	2.90	2.84	2.58	2.35	2.08	2.48	1.23
Price to Earnings (P/E)	31.37	21.30	20.65	21.38	23.53	20.25	19.69	17.04	17.18	25.21
Dividend Yield	0.46%	0.46%	0.50%	0.45%	0.46%	0.49%	0.56%	0.65%	0.58%	1.22%
Earnings Yield	3.19%	4.69%	4.84%	4.68%	4.25%	4.94%	5.08%	5.87%	5.82%	3.97%
Enterprise Value to Invested Capital (EV/IC)	2.77	2.70	2.38	2.37	2.35	2.17	1.90	1.63	1.78	1.03
Enterprise Value to Revenue (EV/Rev)	3.28	3.18	2.92	3.27	3.19	2.89	2.69	2.43	2.84	1.64
Enterprise Value to EBITDA (EV/EBITDA)	13.57	14.90	14.56	15.60	16.64	14.17	13.72	12.12	12.18	11.67
Enterprise Value to EBIT (EV/EBIT)	15.39	17.09	16.79	17.83	19.30	16.29	15.97	14.11	13.98	15.01
Enterprise Value to NOPAT (EV/NOPAT)	19.91	21.51	21.16	22.91	25.01	21.52	21.07	18.65	18.57	30.79
Enterprise Value to Operating Cash Flow (EV/OCF)	27.69	27.99	32.11	39.67	39.69	28.85	20.95	20.56	19.24	11.28
Enterprise Value to Free Cash Flow (EV/FCFF)	36.66	56.19	123.27	0.00	0.00	0.00	0.00	58.79	54.07	43.67
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.32	0.31	0.30	0.40	0.39	0.34	0.35	0.35	0.32	0.39
Long-Term Debt to Equity	0.31	0.30	0.29	0.39	0.38	0.33	0.34	0.34	0.31	0.38
Financial Leverage	0.30	0.28	0.27	0.32	0.30	0.28	0.29	0.34	0.32	0.33
Leverage Ratio	1.61	1.58	1.55	1.66	1.62	1.60	1.57	1.66	1.62	1.66
Compound Leverage Factor	1.54	1.53	1.52	1.61	1.43	1.52	1.46	1.58	1.52	1.78
Debt to Total Capital	24.20%	23.60%	22.83%	28.71%	27.90%	25.28%	25.79%	25.73%	24.11%	27.99%
Short-Term Debt to Total Capital	0.50%	0.57%	0.64%	0.57%	0.56%	0.56%	0.55%	0.53%	0.53%	0.55%
Long-Term Debt to Total Capital	23.69%	23.03%	22.20%	28.15%	27.34%	24.72%	25.24%	25.20%	23.57%	27.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.10%	-0.11%	-0.11%	-0.11%	-0.12%	-0.13%	-0.13%	-0.13%	-0.13%	-0.14%
Common Equity to Total Capital	75.90%	76.51%	77.28%	71.40%	72.22%	74.85%	74.33%	74.39%	76.02%	72.15%
Debt to EBITDA	1.26	1.38	1.45	1.94	2.03	1.68	1.91	1.96	1.69	3.27
Net Debt to EBITDA	0.95	1.06	1.22	1.78	1.82	1.55	1.75	1.79	1.53	2.95
Long-Term Debt to EBITDA	1.24	1.35	1.41	1.90	1.99	1.65	1.87	1.92	1.65	3.21
Debt to NOPAT	1.85	1.99	2.11	2.84	3.06	2.56	2.93	3.01	2.57	8.63
Net Debt to NOPAT	1.40	1.53	1.77	2.61	2.73	2.35	2.69	2.75	2.33	7.77
Long-Term Debt to NOPAT	1.81	1.94	2.05	2.79	2.99	2.50	2.86	2.95	2.52	8.46
Altman Z-Score	5.05	5.02	4.82	3.90	4.06	3.97	3.74	3.42	3.64	2.28
Noncontrolling Interest Sharing Ratio	-0.09%	-0.11%	-0.11%	-0.13%	-0.15%	-0.16%	-0.16%	-0.17%	-0.17%	-0.18%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.37	4.31	4.65	4.39	5.59	4.51	6.32	6.44	6.46	5.91
Quick Ratio	1.57	1.49	1.57	1.43	1.72	1.43	1.90	2.12	1.84	1.88
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-31	-47	-58	-181	-189	-157	-151	-37	-49	-32
Operating Cash Flow to CapEx	262.66%	103.58%	30.92%	109.53%	236.94%	266.40%	91.11%	77.84%	225.83%	156.93%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.71	0.71	0.70	0.64	0.65	0.66	0.63	0.56	0.53	0.50
Accounts Receivable Turnover	7.59	7.75	6.83	6.34	6.94	6.60	6.16	5.14	5.74	4.81
Inventory Turnover	2.00	1.98	1.89	1.73	1.72	1.67	1.55	1.38	1.23	1.17
Fixed Asset Turnover	3.63	3.53	3.52	3.47	3.50	3.36	3.15	2.99	2.76	2.43
Accounts Payable Turnover	10.12	8.81	8.98	7.34	8.89	7.60	8.74	6.86	8.15	5.96
Days Sales Outstanding (DSO)	48.09	47.07	53.41	57.55	52.63	55.32	59.23	71.02	63.61	75.94
Days Inventory Outstanding (DIO)	182.30	184.78	193.12	210.88	212.82	218.45	236.02	265.25	295.89	311.29
Days Payable Outstanding (DPO)	36.07	41.44	40.63	49.75	41.08	48.05	41.75	53.24	44.77	61.20
Cash Conversion Cycle (CCC)	194.32	190.41	205.91	218.69	224.37	225.72	253.50	283.03	314.73	326.03
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	898	923	969	1,105	1,101	1,113	1,142	1,175	1,175	1,124
Invested Capital Turnover	0.87	0.88	0.85	0.80	0.81	0.82	0.76	0.69	0.65	0.63
Increase / (Decrease) in Invested Capital	57	71	90	213	203	190	173	70	74	11
Enterprise Value (EV)	2,485	2,489	2,303	2,621	2,591	2,417	2,166	1,917	2,092	1,154
Market Capitalization	2,312	2,313	2,112	2,324	2,309	2,155	1,891	1,636	1,831	864
Book Value per Share	$32.96	$33.95	$35.32	$36.73	$37.23	$38.63	$39.16	$40.63	$41.59	$38.00
Tangible Book Value per Share	$12.79	$13.81	$15.20	$9.60	$10.24	$11.68	$12.40	$13.76	$14.72	$14.48
Total Capital	955	976	1,006	1,132	1,135	1,136	1,166	1,202	1,203	1,156
Total Debt	231	230	230	325	317	287	301	309	290	324
Total Long-Term Debt	226	225	223	319	310	281	294	303	284	317
Net Debt	174	177	193	298	283	264	276	283	263	291
Capital Expenditures (CapEx)	11	16	16	14	12	13	27	6.37	19	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	294	306	348	387	392	388	414	447	435	435
Debt-free Net Working Capital (DFNWC)	345	354	380	409	420	407	433	468	456	460
Net Working Capital (NWC)	340	349	373	402	414	400	427	462	450	454
Net Nonoperating Expense (NNE)	2.05	1.57	0.67	1.03	1.78	1.70	1.59	0.96	0.87	21
Net Nonoperating Obligations (NNO)	174	177	193	298	283	264	276	283	263	291
Total Depreciation and Amortization (D&A)	5.33	5.20	5.17	5.32	5.78	5.84	5.29	5.33	5.68	5.69
Debt-free, Cash-free Net Working Capital to Revenue	38.77%	39.18%	44.13%	48.20%	48.26%	46.41%	51.31%	56.73%	59.01%	61.80%
Debt-free Net Working Capital to Revenue	45.46%	45.30%	48.15%	50.94%	51.71%	48.60%	53.72%	59.40%	61.82%	65.39%
Net Working Capital to Revenue	44.82%	44.58%	47.34%	50.14%	50.92%	47.84%	52.93%	58.59%	60.95%	64.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.07	$1.03	$1.40	$1.44	$0.59	$1.39	$0.92	$1.43	$1.07	($1.86)
Adjusted Weighted Average Basic Shares Outstanding	22.01M	22.00M	22.04M	22.06M	22.07M	22.06M	22.14M	22.12M	22.07M	22.02M
Adjusted Diluted Earnings per Share	$23,620,001.06	$108,591,001.02	$1.39	$1.44	$0.58	$1.39	$0.92	$1.43	$1.07	($1.86)
Adjusted Weighted Average Diluted Shares Outstanding	22.23M	22.05M	22.07M	22.14M	22.38M	22.17M	22.14M	22.12M	22.07M	22.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	21.99M	22.00M	22.01M	22.02M	22.02M	22.07M	22.01M	21.99M	21.95M	21.27M
Normalized Net Operating Profit after Tax (NOPAT)	26	24	32	33	32	36	25	37	30	30
Normalized NOPAT Margin	12.77%	12.61%	15.77%	15.79%	15.01%	16.64%	14.89%	19.44%	18.33%	16.85%
Pre Tax Income Margin	15.49%	14.54%	20.24%	20.46%	8.25%	19.00%	15.74%	22.08%	19.46%	-17.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	10.37%	9.78%	10.39%	9.77%	10.82%	9.96%	11.04%	11.04%	9.94%	30.84%
Augmented Payout Ratio	11.07%	10.44%	11.17%	10.50%	11.63%	10.71%	18.24%	21.11%	21.32%	172.36%

Financials Breakdown Chart

Key Financial Trends

MGP Ingredients (NASDAQ: MGPI) has experienced notable financial performance fluctuations over the past four years, highlighted by its quarterly reports. Below is an analysis of key trends and significant factors that may impact the company and investor decision-making.

Revenue Growth & Stability: Operating revenue reached $180.8 million in Q4 2024, down somewhat from $214.9 million in Q4 2023 but relatively stable over recent years, demonstrating a consistent revenue base in a challenging market.
Strong Gross Profit Levels: Despite fluctuations, the company held gross profit margins around $62 million to $85 million per quarter, indicating resilience in managing cost of revenue relative to sales.
Solid Cash Flow from Operations: Quarterly net cash from operating activities remained positive, with $28.8 million in Q4 2024 and reaching as high as $43.9 million in Q3 2024, suggesting robust cash generation capability.
Consistent Dividend Payout: MGP Ingredients maintained steady dividend payments of $0.12 per common share each quarter, signaling a commitment to returning value to shareholders.
Equity Growth: Total common equity increased from approximately $724.8 million in Q4 2022 to $914.5 million by Q3 2024, highlighting strengthening shareholder equity positions.

Capex Investments: The company consistently invested in property, plant and equipment, around $12 million to $27 million quarterly, reflecting ongoing capital expenditure for growth or maintenance.
Debt Management Activities: MGP engaged in both issuance and repayment of debt, with net changes varying quarter-to-quarter, indicative of active capital and liquidity management.
Share Repurchase Programs: The firm repurchased common equity periodically, including significant repurchases noted in Q4 2024, which could influence share count and earnings per share metrics.
Inventory Levels and Accounts Receivable: Inventory and accounts receivable remain substantial assets on the balance sheet, requiring efficient management to avoid liquidity issues.

Q4 2024 Net Loss: The company reported a net loss attributable to common shareholders of approximately $41.5 million, a substantial reversal from profitable quarters earlier (e.g., Q3 2024 net income of $23.6 million), mainly due to a large impairment charge of $73.8 million.
Significant Impairment Charges: Q4 2024 included a sizeable impairment expense, severely impacting profitability and operating income, which was negative $30.4 million, compared to positive operating income in previous quarters.

In summary, while MGP Ingredients has demonstrated strong operational cash flow and maintains healthy revenue and equity levels, recent Q4 2024 results highlight challenges with impairments and profitability pressures. Investors should monitor the company’s ability to sustain positive earnings going forward and manage its capital expenditures and debt strategically.

10/24/25 11:14 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About MGP Ingredients' Financials

When does MGP Ingredients' financial year end?

According to the most recent income statement we have on file, MGP Ingredients' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MGP Ingredients' net income changed over the last 2 years?

MGP Ingredients' net income appears to be on a downward trend, with a most recent value of $34.47 million in 2024, falling from $108.87 million in 2022. The previous period was $107.13 million in 2023. See where experts think MGP Ingredients is headed by visiting MGP Ingredients' forecast page.

What is MGP Ingredients' operating income?

MGP Ingredients' total operating income in 2024 was $74.43 million, based on the following breakdown:

Total Gross Profit: $286.32 million
Total Operating Expenses: $211.89 million

How has MGP Ingredients' revenue changed over the last 2 years?

Over the last 2 years, MGP Ingredients' total revenue changed from $782.36 million in 2022 to $703.63 million in 2024, a change of -10.1%.

How much debt does MGP Ingredients have?

MGP Ingredients' total liabilities were at $573.24 million at the end of 2024, a 5.5% increase from 2023, and a 38.9% increase since 2022.

How much cash does MGP Ingredients have?

In the past 2 years, MGP Ingredients' cash and equivalents has ranged from $18.39 million in 2023 to $47.89 million in 2022, and is currently $25.27 million as of their latest financial filing in 2024.

How has MGP Ingredients' book value per share changed over the last 2 years?

Over the last 2 years, MGP Ingredients' book value per share changed from 33.95 in 2022 to 38.00 in 2024, a change of 11.9%.

Related Companies

This page (NASDAQ:MGPI) was last updated on 10/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MGP Ingredients (MGPI) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About MGP Ingredients' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MGP Ingredients (MGPI) Financials

Annual Income Statements for MGP Ingredients

Quarterly Income Statements for MGP Ingredients

Annual Cash Flow Statements for MGP Ingredients

Quarterly Cash Flow Statements for MGP Ingredients

Annual Balance Sheets for MGP Ingredients

Quarterly Balance Sheets for MGP Ingredients

Annual Metrics And Ratios for MGP Ingredients

Quarterly Metrics And Ratios for MGP Ingredients

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About MGP Ingredients' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools